Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer

Checkpoint suppressor 1 (CHES1), a transcriptional regulator, had been dysregulated in many types of malignancies including breast cancer, and its expression level is strongly associated with progression and prognosis of patients. However, the underlying regulatory mechanisms of CHES1 expression in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhaowei, Liu, Shuyan, Feng, Chun, Xu, Fuyi, Kong, Demin, Mi, Jia, Yang, Chunhua, Zhang, Guilong, Wei, Pengfei, Orgil, Buyan-Ochir, Bergquist, Jonas, Tian, Geng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712368/
https://www.ncbi.nlm.nih.gov/pubmed/36450706
http://dx.doi.org/10.1038/s41420-022-01269-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712368/
https://www.ncbi.nlm.nih.gov/pubmed/36450706
http://dx.doi.org/10.1038/s41420-022-01269-x

Ejemplares similares